506 related articles for article (PubMed ID: 29524972)
1. Sociodemographic and survival disparities for histologic variants of bladder cancer.
Jue JS; Koru-Sengul T; Moore KJ; Miao F; Alameddine M; Nahar B; Punnen S; Parekh DJ; Ritch CR; Gonzalgo ML
Can J Urol; 2018 Feb; 25(1):9179-9185. PubMed ID: 29524972
[TBL] [Abstract][Full Text] [Related]
2. Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy.
Fairey AS; Daneshmand S; Wang L; Schuckman A; Lieskovsky G; Djaladat H; Cai J; Miranda G; Skinner EC
Urol Oncol; 2014 Feb; 32(2):110-6. PubMed ID: 23499168
[TBL] [Abstract][Full Text] [Related]
3. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M
Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy.
Ge P; Wang ZC; Yu X; Lin J; He Q
BMC Urol; 2015 May; 15():46. PubMed ID: 26025446
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
[TBL] [Abstract][Full Text] [Related]
6. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy.
Li Q; Assel M; Benfante NE; Pietzak EJ; Herr HW; Donat M; Cha EK; Donahue TF; Bochner BH; Dalbagni G
Eur Urol Focus; 2019 Jan; 5(1):104-108. PubMed ID: 28753857
[TBL] [Abstract][Full Text] [Related]
8. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
Kim SP; Frank I; Cheville JC; Thompson RH; Weight CJ; Thapa P; Boorjian SA
J Urol; 2012 Aug; 188(2):405-9. PubMed ID: 22704101
[TBL] [Abstract][Full Text] [Related]
9. Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
Xylinas E; Rink M; Robinson BD; Lotan Y; Babjuk M; Brisuda A; Green DA; Kluth LA; Pycha A; Fradet Y; Faison T; Lee RK; Karakiewicz PI; Zerbib M; Scherr DS; Shariat SF
Eur J Cancer; 2013 May; 49(8):1889-97. PubMed ID: 23466126
[TBL] [Abstract][Full Text] [Related]
10. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.
Wright JL; Black PC; Brown GA; Porter MP; Kamat AM; Dinney CP; Lin DW
J Urol; 2007 Dec; 178(6):2302-6; discussion 2307. PubMed ID: 17936803
[TBL] [Abstract][Full Text] [Related]
11. Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer.
Boorjian SA; Kim SP; Tollefson MK; Carrasco A; Cheville JC; Thompson RH; Thapa P; Frank I
J Urol; 2013 Jul; 190(1):55-60. PubMed ID: 23313198
[TBL] [Abstract][Full Text] [Related]
12. Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis.
Wang JK; Boorjian SA; Cheville JC; Kim SP; Tarrell RF; Thapa P; Frank I
World J Urol; 2012 Dec; 30(6):801-6. PubMed ID: 23132611
[TBL] [Abstract][Full Text] [Related]
13. Upstaging of nonurothelial histology in bladder cancer at the time of surgical treatment in the National Cancer Data Base.
Cohen AJ; Packiam V; Nottingham C; Steinberg G; Smith ND; Patel S
Urol Oncol; 2017 Jan; 35(1):34.e1-34.e8. PubMed ID: 27592529
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and outcomes of nonurothelial cell carcinoma of the bladder: Results from the National Cancer Data Base.
Royce TJ; Lin CC; Gray PJ; Shipley WU; Jemal A; Efstathiou JA
Urol Oncol; 2018 Feb; 36(2):78.e1-78.e12. PubMed ID: 29162314
[TBL] [Abstract][Full Text] [Related]
15. The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy.
Marks P; Gild P; Soave A; Janisch F; Minner S; Engel O; Vetterlein MW; Shariat SF; Sauter G; Dahlem R; Fisch M; Rink M
Surg Oncol; 2019 Mar; 28():208-213. PubMed ID: 30851902
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder.
Minato A; Noguchi H; Tomisaki I; Fukuda A; Kubo T; Nakayama T; Fujimoto N
Cancer Control; 2018; 25(1):1073274818800269. PubMed ID: 30213195
[TBL] [Abstract][Full Text] [Related]
17. Assessing the Impact of Time to Cystectomy for Variant Histology of Urothelial Bladder Cancer.
Lin-Brande M; Pearce SM; Ashrafi AN; Nazemi A; Burg ML; Ghodoussipour S; Miranda G; Djaladat H; Schuckman A; Daneshmand S
Urology; 2019 Nov; 133():157-163. PubMed ID: 31421144
[TBL] [Abstract][Full Text] [Related]
18. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy.
Mitra AP; Alemozaffar M; Harris BN; Schuckman AK; Skinner EC; Daneshmand S
Urology; 2014 Dec; 84(6):1420-6. PubMed ID: 25306479
[TBL] [Abstract][Full Text] [Related]
19. The impact of histological variants on outcomes after open radical cystectomy for muscle-invasive urothelial bladder cancer: results from a single tertiary referral centre.
Naspro R; Finati M; Roscigno M; Pellucchi F; La Croce G; Sodano M; Manica M; Chinaglia D; Da Pozzo LF
World J Urol; 2021 Jun; 39(6):1917-1926. PubMed ID: 32696127
[TBL] [Abstract][Full Text] [Related]
20. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
